OKLAHOMA CITY, Jan. 4, 2011 /PRNewswire/ -- Graymark Healthcare Inc. (Nasdaq: GRMH ), the nation's second largest provider of diagnostic sleep services and an innovator in comprehensive care for obstructive sleep apnea (OSA), serviced a record number of OSA patients in the fourth quarter of 2010, with a 16% increase in CPAP set-ups and a 75% increase in re-supply shipments, as compared to fourth quarter of 2009.
Graymark specializes in the diagnosis and treatment of sleep apnea, which is characterized by abnormal pauses in breathing during sleep where each pause or "apnea" can last from a few seconds to minutes, and can occur from five to more than 30 times per hour. OSA is the most common form of sleep apnea, where the soft tissue in the airway obstructs breathing. OSA correlates highly with stroke, cardiac disease, obesity and other conditions that lead to early death and morbidity. However, 80% of patients affected by OSA go completely undiagnosed and patient treatment compliance is often a challenge.
In an effort to improve clinical outcomes, Graymark has been pioneering better techniques to more quickly and effectively diagnosis and treat patients diagnosed with OSA. In the fourth quarter of 2009, Graymark Healthcare launched a new comprehensive care model to improve the conversion rate of OSA patients into successfully using a CPAP (Continuous Positive Airway Pressure) device.
Graymark's effective five-step clinical approach to managing sleep disorders includes a convenient referral process, accurate and timely assessment, diagnosis, treatment and long-term follow-up to maximize patient compliance. All steps are managed by a board certified Sleep Medicine physician. By more completely integrating the diagnostic and treatment processes, Graymark has substantially improved patient compliance with CPAP care and overall disease management.